Published in J Clin Oncol on June 10, 2008
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene (2010) 9.66
Emerging role of Notch in stem cells and cancer. Cancer Lett (2008) 1.88
Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer. Crit Rev Oncol Hematol (2010) 1.82
Cigarette smoking and lung cancer--relative risk estimates for the major histological types from a pooled analysis of case-control studies. Int J Cancer (2011) 1.74
Gastric cancer-molecular and clinical dimensions. Nat Rev Clin Oncol (2013) 1.72
Implications of cancer stem cell theory for cancer chemoprevention by natural dietary compounds. J Nutr Biochem (2011) 1.10
Surgery for NSCLC in the era of personalized medicine. Nat Rev Clin Oncol (2013) 1.05
A phase II study of RO4929097 in metastatic colorectal cancer. Eur J Cancer (2012) 1.05
Rapid selection and proliferation of CD133+ cells from cancer cell lines: chemotherapeutic implications. PLoS One (2010) 0.98
Anterior gradient protein 2 expression in high grade head and neck squamous cell carcinoma correlated with cancer stem cell and epithelial mesenchymal transition. Oncotarget (2015) 0.96
Small cell lung cancer: will recent progress lead to improved outcomes? Clin Cancer Res (2015) 0.94
Permanently blocked stem cells derived from breast cancer cell lines. Stem Cells (2010) 0.93
Regulation of lung cancer metastasis by Klf4-Numb-like signaling. Cancer Res (2013) 0.91
Tumor heterogeneity and resistance to EGFR-targeted therapy in advanced nonsmall cell lung cancer: challenges and perspectives. Onco Targets Ther (2014) 0.91
Lung cancer stem cells: progress and prospects. Cancer Lett (2012) 0.90
Chemotherapy and signaling: How can targeted therapies supercharge cytotoxic agents? Cancer Biol Ther (2010) 0.89
Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer. Mol Cancer (2014) 0.87
Molecular pathogenesis of sporadic melanoma and melanoma-initiating cells. Arch Pathol Lab Med (2010) 0.84
Lung cancer: developmental networks gone awry? Cancer Biol Ther (2009) 0.83
Aberrant microRNAs expression in CD133⁺/CD326⁺ human lung adenocarcinoma initiating cells from A549. Mol Cells (2012) 0.83
A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors. Invest New Drugs (2014) 0.83
Combination of circulating tumor cell enumeration and tumor marker detection in predicting prognosis and treatment effect in metastatic castration-resistant prostate cancer. Oncotarget (2015) 0.82
Welding and lung cancer in a pooled analysis of case-control studies. Am J Epidemiol (2013) 0.81
The role of Sox genes in lung morphogenesis and cancer. Int J Mol Sci (2012) 0.81
Specific Biomarkers Are Associated with Docetaxeland Gemcitabine-Resistant NSCLC Cell Lines. Transl Oncol (2012) 0.81
Stemness and plasticity of lung cancer cells: paving the road for better therapy. Onco Targets Ther (2014) 0.80
Gene expression profiling in human lung development: an abundant resource for lung adenocarcinoma prognosis. PLoS One (2014) 0.80
Norcantharidin, derivative of cantharidin, for cancer stem cells. Evid Based Complement Alternat Med (2013) 0.80
No small matter: microRNAs - key regulators of cancer stem cells. Int J Clin Exp Med (2010) 0.79
E-cadherin controls bronchiolar progenitor cells and onset of preneoplastic lesions in mice. Neoplasia (2012) 0.79
Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds. Semin Cancer Biol (2015) 0.79
Nrf2 and Notch Signaling in Lung Cancer: Near the Crossroad. Oxid Med Cell Longev (2016) 0.78
The controversial clinicobiological role of breast cancer stem cells. J Oncol (2009) 0.78
Small-cell lung cancer: translational research enroute to therapeutic advances. Oncology (Williston Park) (2008) 0.77
Novel therapeutic approaches for small cell lung cancer: the future has arrived. Curr Probl Cancer (2012) 0.77
Cisplatin-enriching cancer stem cells confer multidrug resistance in non-small cell lung cancer via enhancing TRIB1/HDAC activity. Cell Death Dis (2017) 0.75
Targeting the Notch signaling pathway in cancer therapeutics. Thorac Cancer (2014) 0.75
Drug exposure in a metastatic human lung adenocarcinoma cell line gives rise to cells with differing adhesion, proliferation, and gene expression: Implications for cancer chemotherapy. Mol Med Rep (2015) 0.75
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
The hallmarks of cancer. Cell (2000) 113.05
Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A (2003) 59.17
Smoking and carcinoma of the lung; preliminary report. Br Med J (1950) 55.13
Stem cells, cancer, and cancer stem cells. Nature (2001) 50.27
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med (1997) 32.63
Cancer statistics, 2006. CA Cancer J Clin (2006) 30.71
Notch signaling: cell fate control and signal integration in development. Science (1999) 28.83
Identification of a cancer stem cell in human brain tumors. Cancer Res (2003) 24.02
Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med (1996) 17.51
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev (2001) 15.97
Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell (2005) 15.06
A stem cell molecular signature. Science (2002) 14.47
Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res (2005) 13.89
Cancer stem cells: an old idea--a paradigm shift. Cancer Res (2006) 9.76
Applying the principles of stem-cell biology to cancer. Nat Rev Cancer (2003) 8.95
Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ (2007) 8.08
Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol (2006) 7.87
Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature (2003) 6.07
Characterization of clonogenic multiple myeloma cells. Blood (2003) 5.35
Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res (2007) 5.32
Teratogen-mediated inhibition of target tissue response to Shh signaling. Science (1998) 5.28
HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr Biol (2006) 5.17
Terminal bronchioles harbor a unique airway stem cell population that localizes to the bronchoalveolar duct junction. Am J Pathol (2002) 4.18
Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. Annu Rev Cell Dev Biol (2001) 4.11
Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nat Med (2002) 4.04
Clara cell secretory protein-expressing cells of the airway neuroepithelial body microenvironment include a label-retaining subset and are critical for epithelial renewal after progenitor cell depletion. Am J Respir Cell Mol Biol (2001) 4.03
Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell (1991) 3.95
Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Proc Natl Acad Sci U S A (1999) 3.91
Sonic hedgehog is essential to foregut development. Nat Genet (1998) 3.50
Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells (2007) 3.47
Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model. Cancer Cell (2003) 3.31
p38alpha MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation. Nat Genet (2007) 3.30
Sonic hedgehog regulates branching morphogenesis in the mammalian lung. Curr Biol (1998) 3.29
Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma. Proc Natl Acad Sci U S A (2007) 3.23
Discovery of an oncogenic activity in p27Kip1 that causes stem cell expansion and a multiple tumor phenotype. Genes Dev (2007) 3.00
Notch signaling induces cell cycle arrest in small cell lung cancer cells. Cancer Res (2001) 2.79
Basic helix-loop-helix transcription factors regulate the neuroendocrine differentiation of fetal mouse pulmonary epithelium. Development (2000) 2.73
Involvement of Sonic hedgehog (Shh) in mouse embryonic lung growth and morphogenesis. Development (1997) 2.61
Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers. Cancer Res (2007) 2.54
Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation. Clin Cancer Res (2002) 2.50
PTENless means more. Dev Biol (2004) 2.31
Conditional clara cell ablation reveals a self-renewing progenitor function of pulmonary neuroendocrine cells. Am J Physiol Lung Cell Mol Physiol (2000) 2.28
Molecular phenotype of airway side population cells. Am J Physiol Lung Cell Mol Physiol (2003) 2.20
The pathways to tumor suppression via route p38. Trends Biochem Sci (2007) 2.15
Conservation of the Drosophila lateral inhibition pathway in human lung cancer: a hairy-related protein (HES-1) directly represses achaete-scute homolog-1 expression. Proc Natl Acad Sci U S A (1997) 2.00
Identification of a human achaete-scute homolog highly expressed in neuroendocrine tumors. Proc Natl Acad Sci U S A (1993) 1.97
Valproic acid activates notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells. Oncologist (2007) 1.96
ALDH1A1 and ALDH3A1 expression in lung cancers: correlation with histologic type and potential precursors. Lung Cancer (2007) 1.93
Embryonic mouse lung epithelial progenitor cells co-express immunohistochemical markers of diverse mature cell lineages. J Histochem Cytochem (1996) 1.92
Side population cells and Bcrp1 expression in lung. Am J Physiol Lung Cell Mol Physiol (2003) 1.90
Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice. J Clin Invest (2007) 1.86
Ligand-dependent activation of the hedgehog pathway in glioma progenitor cells. Oncogene (2007) 1.76
Notch in lung development and lung cancer. Semin Cancer Biol (2004) 1.73
INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions. IUBMB Life (2007) 1.63
Identification of uPAR-positive chemoresistant cells in small cell lung cancer. PLoS One (2007) 1.54
Morphologic and biochemical study of pulmonary changes induced by bleomycin in mice. Lab Invest (1976) 1.54
Isolation of multipotent neural crest-derived stem cells from the adult mouse cornea. Stem Cells (2006) 1.49
Identification of pulmonary Oct-4+ stem/progenitor cells and demonstration of their susceptibility to SARS coronavirus (SARS-CoV) infection in vitro. Proc Natl Acad Sci U S A (2006) 1.36
Demonstration of the stem cell nature of clonogenic tumor cells from lung cancer patients. Stem Cells (1982) 1.35
Wnt and Hedgehog are critical mediators of cigarette smoke-induced lung cancer. PLoS One (2006) 1.34
Lung stem cells. Cell Tissue Res (2007) 1.30
A temporal and biochemical link between growth factor-activated MAP kinases, cyclin D1 induction and cell cycle entry. Prog Cell Cycle Res (1996) 1.29
Functional studies of the MEN1 gene. J Intern Med (2003) 1.25
Predicting survival within the lung cancer histopathological hierarchy using a multi-scale genomic model of development. PLoS Med (2006) 1.21
Respiratory failure due to differentiation arrest and expansion of alveolar cells following lung-specific loss of the transcription factor C/EBPalpha in mice. Mol Cell Biol (2006) 1.21
The urokinase receptor as a potential target in cancer therapy. Curr Pharm Des (2004) 1.16
A transcriptional profiling study of CCAAT/enhancer binding protein targets identifies hepatocyte nuclear factor 3 beta as a novel tumor suppressor in lung cancer. Cancer Res (2004) 1.13
Mammary stem cell number as a determinate of breast cancer risk. Breast Cancer Res (2007) 1.12
Hedgehog signaling. J Cell Sci (2007) 1.11
p18Ink4c collaborates with Men1 to constrain lung stem cell expansion and suppress non-small-cell lung cancers. Cancer Res (2007) 1.10
Notch signaling inhibits growth of the human lung adenocarcinoma cell line A549. Oncol Rep (2007) 1.05
Characterization and enrichment of murine hemopoietic stem cells by fluorescence activated cell sorting. Exp Hematol (1981) 1.03
Small cell lung cancer: state-of-the-art therapy in 1996. Chest (1997) 1.02
From fruitflies to mammals: mechanisms of signalling via the Sonic hedgehog pathway in lung development. Respir Res (2000) 0.96
Animal embryonic stem (ES) cells: self-renewal, pluripotency, transgenesis and nuclear transfer. Hum Cell (2004) 0.94
Signaling in adult stem cells. Front Biosci (2007) 0.87
Advancing the field of lung stem cell biology. Front Biosci (2007) 0.83
A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet (2007) 9.47
Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature (2003) 8.14
Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet (2004) 7.78
Medulloblastoma growth inhibition by hedgehog pathway blockade. Science (2002) 6.53
Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance. Cancer Res (2008) 3.57
Inhibition of SIRT1 reactivates silenced cancer genes without loss of promoter DNA hypermethylation. PLoS Genet (2006) 3.54
A primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro. Cancer Res (2009) 3.38
Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma. Proc Natl Acad Sci U S A (2007) 3.23
Interfering with resistance to smoothened antagonists by inhibition of the PI3K pathway in medulloblastoma. Sci Transl Med (2010) 2.86
Epigenetic inactivation of the canonical Wnt antagonist SRY-box containing gene 17 in colorectal cancer. Cancer Res (2008) 2.16
Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancer. Cancer Res (2008) 1.99
A crucial requirement for Hedgehog signaling in small cell lung cancer. Nat Med (2011) 1.97
Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors. Nat Genet (2003) 1.77
Seneca Valley virus, a systemically deliverable oncolytic picornavirus, and the treatment of neuroendocrine cancers. J Natl Cancer Inst (2007) 1.52
Notch signaling induces rapid degradation of achaete-scute homolog 1. Mol Cell Biol (2002) 1.51
Cancer stem cells in lung cancer: Evidence and controversies. Respirology (2013) 1.46
Cooperation between the Hic1 and Ptch1 tumor suppressors in medulloblastoma. Genes Dev (2008) 1.42
Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett's metaplasia. Gastroenterology (2010) 1.33
Hedgehog overexpression is associated with stromal interactions and predicts for poor outcome in breast cancer. Cancer Res (2011) 1.25
Novel systemic therapies for small cell lung cancer. J Natl Compr Canc Netw (2008) 1.18
Lung cancer: future directions. Respirology (2007) 1.14
Developmental signalling pathways in lung cancer. Respirology (2006) 1.12
Self-renewal of acute lymphocytic leukemia cells is limited by the Hedgehog pathway inhibitors cyclopamine and IPI-926. PLoS One (2010) 1.06
The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer. Thorax (2013) 1.03
Novel therapeutic targets in non-small cell lung cancer. Curr Opin Pharmacol (2013) 1.02
The Hedgehog signalling pathway in breast development, carcinogenesis and cancer therapy. Breast Cancer Res (2013) 1.01
Changes in aldehyde dehydrogenase-1 expression during neoadjuvant chemotherapy predict outcome in locally advanced breast cancer. Breast Cancer Res (2014) 0.98
Enhanced efficacy of local etoposide delivery by poly(ether-anhydride) particles against small cell lung cancer in vivo. Biomaterials (2009) 0.96
Next-generation sequence analysis of cancer xenograft models. PLoS One (2013) 0.94
Ancient origin of the new developmental superfamily DANGER. PLoS One (2007) 0.94
Pentastatin-1, a collagen IV derived 20-mer peptide, suppresses tumor growth in a small cell lung cancer xenograft model. BMC Cancer (2010) 0.93
A histological survey of green fluorescent protein expression in 'green' mice: implications for stem cell research. Pathology (2007) 0.93
Hedgehog signaling regulates FOXA2 in esophageal embryogenesis and Barrett's metaplasia. J Clin Invest (2014) 0.92
Mechanisms of Hedgehog signalling in cancer. Growth Factors (2011) 0.91
DANGER, a novel regulatory protein of inositol 1,4,5-trisphosphate-receptor activity. J Biol Chem (2006) 0.89
Interaction of smoothened with integrin-linked kinase in primary cilia mediates Hedgehog signalling. EMBO Rep (2013) 0.89
Sox9 drives columnar differentiation of esophageal squamous epithelium: a possible role in the pathogenesis of Barrett's esophagus. Am J Physiol Gastrointest Liver Physiol (2012) 0.88
Just say no to ATOH: how HIC1 methylation might predispose medulloblastoma to lineage addiction. Cancer Res (2008) 0.86
Prevailing importance of the hedgehog signaling pathway and the potential for treatment advancement in sarcoma. Pharmacol Ther (2012) 0.83
Mutational analysis of hedgehog signaling pathway genes in human malignant mesothelioma. PLoS One (2013) 0.79
Sustained Low-Dose Treatment with the Histone Deacetylase Inhibitor LBH589 Induces Terminal Differentiation of Osteosarcoma Cells. Sarcoma (2013) 0.78
Visualizing renal primary cilia. Nephrology (Carlton) (2013) 0.76
Peptide receptor chemoradionuclide therapy in small cell carcinoma: from bench to bedside. Eur J Nucl Med Mol Imaging (2014) 0.75